World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
85
Citations
43089
World Ranking
14374
National Ranking
7267

Overview

Natasha Rekhtman is affiliated with Memorial Sloan Kettering Cancer Center in the United States and has a substantial body of work centered on pulmonary medicine and oncology. Their primary research contributions focus on lung cancer, encompassing aspects of diagnosis, treatment, genomics, and pathology.

The scientist has published extensively in several high-impact journals, with the most frequent publication venues including:

  • Journal of Thoracic Oncology
  • Journal of Clinical Oncology
  • Clinical Cancer Research
  • Cancer Research
  • Annals of Oncology

Research topics notably emphasized in their work comprise:

  • Lung Cancer Treatments and Mutations
  • Lung Cancer Research Studies
  • Cancer Genomics and Diagnostics
  • Neuroendocrine Tumor Research Advances
  • Lung Cancer Diagnosis and Treatment
  • Cancer Immunotherapy and Biomarkers
  • Neuroblastoma Research and Treatments

Their research spans key fields of study such as Medicine and Biochemistry, Genetics and Molecular Biology. More specifically, they focus on subfields including Pulmonary and Respiratory Medicine, Oncology, Molecular Biology, Cancer Research, and Epidemiology.

Natasha Rekhtman has contributed to several frequently cited papers, among them:

  • The 2021 WHO Classification of Lung Tumors: Impact of Advances Since 2015 (2021) published in the Journal of Thoracic Oncology
  • A Grading System for Invasive Pulmonary Adenocarcinoma: A Proposal From the International Association for the Study of Lung Cancer Pathology Committee (2020) published in the Journal of Thoracic Oncology
  • Regenerative lineages and immune-mediated pruning in lung cancer metastasis (2020) published in Nature Medicine
  • SCLC Subtypes Defined by ASCL1, NEUROD1, POU2F3, and YAP1: A Comprehensive Immunohistochemical and Histopathologic Characterization (2020) published in the Journal of Thoracic Oncology
  • Signatures of plasticity, metastasis, and immunosuppression in an atlas of human small cell lung cancer (2021) published in Cancer Cell

Collaborations are an important aspect of their work, with frequent co-authors including:

  • Charles M. Rudin
  • William D. Travis
  • Jason C. Chang
  • Marc Ladanyi
  • Marina K. Baine

Best Publications

  • Mutational landscape determines sensitivity to PD-1 blockade in non–small cell lung cancer

    Naiyer A. Rizvi;Naiyer A. Rizvi;Matthew D. Hellmann;Matthew D. Hellmann;Alexandra Snyder;Alexandra Snyder;Pia Kvistborg

  • Comprehensive molecular profiling of lung adenocarcinoma: The cancer genome atlas research network

    Eric A. Collisson;Joshua D. Campbell;Angela N. Brooks;Angela N. Brooks;Alice H. Berger

  • Comprehensive genomic characterization of squamous cell lung cancers

    Peter S. Hammerman;Doug Voet;Michael S. Lawrence;Douglas Voet

  • Analysis of Tumor Specimens at the Time of Acquired Resistance to EGFR-TKI Therapy in 155 Patients with EGFR-Mutant Lung Cancers

    Helena A. Yu;Maria E. Arcila;Natasha Rekhtman;Camelia S. Sima

  • Neoadjuvant PD-1 Blockade in Resectable Lung Cancer

    Patrick M. Forde;Jamie E. Chaft;Kellie N. Smith;Valsamo Anagnostou

  • Molecular Determinants of Response to Anti-Programmed Cell Death (PD)-1 and Anti-Programmed Death-Ligand 1 (PD-L1) Blockade in Patients With Non-Small-Cell Lung Cancer Profiled With Targeted Next-Generation Sequencing.

    Hira Rizvi;Francisco Sanchez-Vega;Konnor La;Walid Chatila

  • Genomic Features of Response to Combination Immunotherapy in Patients with Advanced Non-Small-Cell Lung Cancer.

    Matthew D. Hellmann;Tavi Nathanson;Hira Rizvi;Benjamin C. Creelan

  • Pneumonitis in Patients Treated With Anti–Programmed Death-1/Programmed Death Ligand 1 Therapy

    Jarushka Naidoo;Xuan Wang;Xuan Wang;Xuan Wang;Kaitlin M. Woo;Kaitlin M. Woo;Tunc Iyriboz;Tunc Iyriboz

  • The 2021 WHO Classification of Lung Tumors: Impact of advances since 2015.

    Andrew G. Nicholson;Ming S. Tsao;Mary Beth Beasley;Alain C. Borczuk

  • In vivo engineering of oncogenic chromosomal rearrangements with the CRISPR/Cas9 system

    Danilo Maddalo;Eusebio Manchado;Carla P. Concepcion;Ciro Bonetti

  • Response to MET Inhibitors in Patients with Stage IV Lung Adenocarcinomas Harboring MET Mutations Causing Exon 14 Skipping

    Paul K. Paik;Paul K. Paik;Alexander Drilon;Alexander Drilon;Pang Dian Fan;Helena Yu;Helena Yu

  • Prospective Comprehensive Molecular Characterization of Lung Adenocarcinomas for Efficient Patient Matching to Approved and Emerging Therapies.

    Emmet J. Jordan;Hyunjae R. Kim;Maria E. Arcila;David Barron

  • Neuroendocrine tumors of the lung: an update.

    Natasha Rekhtman

  • EGFR Exon 20 Insertion Mutations in Lung Adenocarcinomas: Prevalence, Molecular Heterogeneity, and Clinicopathologic Characteristics

    Maria E. Arcila;Khedoudja Nafa;Jamie E. Chaft;Natasha Rekhtman

  • Chemosensitive Relapse in Small Cell Lung Cancer Proceeds through an EZH2-SLFN11 Axis

    Eric E. Gardner;Eric E. Gardner;Benjamin H. Lok;Valentina E. Schneeberger;Patrice Desmeules

  • p40 (ΔNp63) is superior to p63 for the diagnosis of pulmonary squamous cell carcinoma.

    Justin A Bishop;Julie Teruya-Feldstein;William H Westra;Giuseppe Pelosi

  • Cabozantinib in patients with advanced RET-rearranged non-small-cell lung cancer: an open-label, single-centre, phase 2, single-arm trial

    Alexander Drilon;Natasha Rekhtman;Maria Arcila;Lu Wang

  • Immunohistochemical Algorithm for Differentiation of Lung Adenocarcinoma and Squamous Cell Carcinoma Based on Large Series of Whole-Tissue Sections With Validation in Small Specimens

    Natasha Rekhtman;Daphne C Ang;Camelia S Sima;William D Travis

  • Clarifying the Spectrum of Driver Oncogene Mutations in Biomarker-Verified Squamous Carcinoma of Lung: Lack of EGFR/KRAS and Presence of PIK3CA/AKT1 Mutations

    Natasha Rekhtman;Paul K. Paik;Maria E. Arcila;Laura J. Tafe

  • Next-Generation Sequencing of Pulmonary Large Cell Neuroendocrine Carcinoma Reveals Small Cell Carcinoma–like and Non–Small Cell Carcinoma–like Subsets

    Natasha Rekhtman;Maria C. Pietanza;Matthew D. Hellmann;Jarushka Naidoo

Frequent Co-Authors

William D. Travis
William D. Travis Memorial Sloan Kettering Cancer Center
Charles M. Rudin
Charles M. Rudin Memorial Sloan Kettering Cancer Center
Mark G. Kris
Mark G. Kris Memorial Sloan Kettering Cancer Center
Marc Ladanyi
Marc Ladanyi Memorial Sloan Kettering Cancer Center
Gregory J. Riely
Gregory J. Riely Memorial Sloan Kettering Cancer Center
Maria E. Arcila
Maria E. Arcila Memorial Sloan Kettering Cancer Center
Alexander Drilon
Alexander Drilon Memorial Sloan Kettering Cancer Center
Matthew D. Hellmann
Matthew D. Hellmann Memorial Sloan Kettering Cancer Center
David R. Jones
David R. Jones Memorial Sloan Kettering Cancer Center
John T. Poirier
John T. Poirier New York University Langone Medical Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

The pathway to a medical career in the USA is diverse, with many related online degrees and certifications offering flexibility and affordability. For students aiming for advanced practice roles, the cheapest online dnp programs provide a more accessible option to earn a Doctor of Nursing Practice without heavy financial burden.

If you're interested in pharmacy, consider the 3-year online pharmd route. This accelerated option can help you become a pharmacist sooner, while balancing work and study.

For those looking to combine healthcare and technology, accredited healthcare informatics degree programs are increasingly popular. These programs prepare graduates to manage patient data and lead innovation in healthcare delivery.

Entry-level positions such as medical billing and coding can also be accessed quickly with a medical coding certification online. This certification opens the door to important administrative roles in clinics and hospitals, often without the need for years in a traditional classroom setting.

Exploring these related online degrees can help you find the right career path in the healthcare field, fitting your interests and lifestyle.

Best Scientists Citing Natasha Rekhtman

Trending Scientists